AXT Inc (NASDAQ:AXTI – Get Free Report) Director Jesse Chen sold 6,172 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $115.24, for a total value of $711,261.28. Following the completion of the transaction, the director owned 50,275 shares in the company, valued at $5,793,691. This represents a 10.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Jesse Chen also recently made the following trade(s):
- On Friday, June 12th, Jesse Chen sold 13,000 shares of AXT stock. The stock was sold at an average price of $95.77, for a total value of $1,245,010.00.
- On Wednesday, June 10th, Jesse Chen sold 9,000 shares of AXT stock. The stock was sold at an average price of $86.73, for a total value of $780,570.00.
- On Tuesday, June 9th, Jesse Chen sold 1,500 shares of AXT stock. The shares were sold at an average price of $93.30, for a total value of $139,950.00.
- On Monday, June 8th, Jesse Chen sold 6,000 shares of AXT stock. The shares were sold at an average price of $94.00, for a total value of $564,000.00.
- On Thursday, June 4th, Jesse Chen sold 6,133 shares of AXT stock. The stock was sold at an average price of $108.28, for a total value of $664,081.24.
- On Wednesday, June 3rd, Jesse Chen sold 4,000 shares of AXT stock. The stock was sold at an average price of $111.36, for a total value of $445,440.00.
AXT Stock Performance
Shares of AXTI opened at $84.57 on Friday. The firm has a market cap of $5.53 billion, a P/E ratio of -272.80 and a beta of 1.80. AXT Inc has a 12-month low of $1.80 and a 12-month high of $143.16. The company’s 50-day moving average price is $96.87 and its 200 day moving average price is $52.76.
Wall Street Analysts Forecast Growth
AXTI has been the subject of several research reports. Northland Securities set a $125.00 target price on shares of AXT in a report on Wednesday, June 3rd. Weiss Ratings upgraded AXT from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 27th. B. Riley Financial raised their price target on AXT to $21.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th. Finally, Wedbush lifted their price objective on AXT from $8.50 to $28.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $43.80.
Get Our Latest Research Report on AXTI
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in AXTI. American Capital Advisory LLC purchased a new stake in AXT during the 1st quarter worth approximately $27,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of AXT in the first quarter worth $31,000. XTX Topco Ltd acquired a new position in shares of AXT in the second quarter worth $42,000. Jefferies Financial Group Inc. purchased a new stake in shares of AXT during the third quarter worth $52,000. Finally, Leonteq Securities AG purchased a new stake in shares of AXT during the first quarter worth $57,000. Institutional investors and hedge funds own 49.52% of the company’s stock.
About AXT
AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.
AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.
Featured Stories
- Five stocks we like better than AXT
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for AXT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXT and related companies with MarketBeat.com's FREE daily email newsletter.
